Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Days Payable : 0.00 (As of Apr. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Days Payable?

Advanced Proteome Therapeutics's average Accounts Payable for the three months ended in Apr. 2023 was $0.38 Mil. Advanced Proteome Therapeutics's Cost of Goods Sold for the three months ended in Apr. 2023 was $0.00 Mil.

The historical rank and industry rank for Advanced Proteome Therapeutics's Days Payable or its related term are showing as below:

APTCF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 149.7
* Ranked among companies with meaningful Days Payable only.

Advanced Proteome Therapeutics's Days Payable stayed the same from Apr. 2022 (0.00) to Apr. 2023 (0.00). stayed the same

Advanced Proteome Therapeutics Days Payable Historical Data

The historical data trend for Advanced Proteome Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Days Payable Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Days Payable

Get a 7-Day Free Trial

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Advanced Proteome Therapeutics's Days Payable

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Days Payable falls into.

Advanced Proteome Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Advanced Proteome Therapeutics's Days Payable for the fiscal year that ended in Jul. 2022 is calculated as

	Days Payable (A: Jul. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jul. 2021 )	+	Accounts Payable (A: Jul. 2022 ))	/	count )	/	Cost of Goods Sold (A: Jul. 2022 )	*	Days in Period
=	( (0.58	+	0.665)	/	2 )	/	0	*	365
=	0.6225					/	0	*	365
=	N/A

Advanced Proteome Therapeutics's Days Payable for the quarter that ended in Apr. 2023 is calculated as:

	Days Payable (Q: Apr. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jan. 2023 )	+	Accounts Payable (Q: Apr. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Apr. 2023 )	*	Days in Period
=	( (0.712	+	0.054)	/	2 )	/	0	*	365 / 4
=	0.383					/	0	*	365 / 4
=	N/A

Advanced Proteome Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

0E81:Germany APC.H:Canada

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018